source
- RegCell secures multi-million dollar Series A to advance Nobel-winning regulatory T-cell therapyRegCell, a biotech founded by Nobel laureate Shimon Sakaguchi, announced a new financing round to move its regulatory T-cell (Treg) program toward clinical testing. The company’s CEO Michael McCul…
- FDA launches Operation TrialBlazer to accelerate early-stage drug trials and bring research back to the U.S.The FDA announced it is now accepting applications for Operation TrialBlazer, an expedited IND pilot program. The program pairs drug sponsors with qualified U.S. research institutions to cut the r…